alvaiz Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Alvaiz, and when can generic versions of Alvaiz launch?
Alvaiz is a drug marketed by Teva Pharms Inc and is included in one NDA.
The generic ingredient in ALVAIZ is eltrombopag choline. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the eltrombopag choline profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for alvaiz?
- What are the global sales for alvaiz?
- What is Average Wholesale Price for alvaiz?
Summary for alvaiz
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Drug Prices: | Drug price information for alvaiz |
What excipients (inactive ingredients) are in alvaiz? | alvaiz excipients list |
DailyMed Link: | alvaiz at DailyMed |
![alvaiz drug patent expirations Drug patent expirations by year for alvaiz](/p/graph/s/t/alvaiz-patent-expirations.png)
![Drug Prices for alvaiz](/p/graph/drug-price/alvaiz.png)
Pharmacology for alvaiz
US Patents and Regulatory Information for alvaiz
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Pharms Inc | ALVAIZ | eltrombopag choline | TABLET;ORAL | 216774-001 | Nov 29, 2023 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva Pharms Inc | ALVAIZ | eltrombopag choline | TABLET;ORAL | 216774-004 | Nov 29, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva Pharms Inc | ALVAIZ | eltrombopag choline | TABLET;ORAL | 216774-002 | Nov 29, 2023 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva Pharms Inc | ALVAIZ | eltrombopag choline | TABLET;ORAL | 216774-003 | Nov 29, 2023 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |